- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00308126
Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery
Phase IV, Open-Label, Randomized, Albumin-Controlled, Parallel Group, Multicenter Study to Evaluate the Effect of Medium Molecule HES (130/0.4) in Complications for Patients After Abdominal Surgery
Purpose: To compare the incidence of post-surgery complications and evaluate relevant parameters within 28 days after an operation in HES (130/0.4) and albumin treated groups
Study Design: Open-label, active controlled, parallel group, randomized, multi-center study. Per protocol, 624 patients required in 6 study centers.
Hypothesis: No difference in rate of postoperative (post-op) complications between HES and albumin groups
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Since the application of surgical operations, postoperative complications have been the area surgeons explored the most. Though surgical technological advances make it possible for most patients to recover from an operation, the prevention and management of the postoperative complications are still important for surgeons.
Traditionally, the level of albumin is an important marker for the prognosis of the patient. When the level of albumin is below 35 g/L, the mortality rate and other complications will increase significantly, so albumin has become the widely used colloid liquid in fluid therapy for postoperative patients. Actually, the body cannot utilize exogenous albumin and it takes 6-7 days for the body to synthesize new albumin. There is dispute concerning whether albumin should be used in postoperative treatments for severely ill patients. The well-known SAFE study found there was no difference in the efficacy between albumin and crystalloids for severe patients in the 28-day observation time. A meta analysis of 24 studies involving 1419 patients came to the conclusion that administration of albumin could increase the mortality rate in patients. The high price of albumin is another target for extensive criticism.
On the other hand, maintaining colloid osmotic pressure at a certain level in the circulatory system is essential for postoperative patients to stabilize hemodynamics, reduce tissue edema, improve recovery, so it is beneficial for patients to replace albumin with Voluven (130/0.4). Voluven (130/0.4) is a medium-molecular-weight hydroxyethyl starch produced by Fresenius Kabi Pharmaceutical Co. Ltd, and is widely used clinically in volume replacement therapy. Its efficacy and safety are proved by its clinical practices, however, its effect in patients with postoperative complications is not clear. The study will compare the effect of Voluven (130/0.4) and albumin on the occurrence of postoperative complications in patients with an abdominal operation to provide guidance on selection of safe and economic volume replacement therapy for postoperative patients.
STUDY OBJECTIVES
To compare the effect of Voluven (130/0.4) to that of albumin for occurrence of postoperative complications in patients with abdominal surgery from the day of the operation to 28th day after the operation.
Tipo di studio
Iscrizione
Fase
- Fase 4
Contatti e Sedi
Luoghi di studio
-
-
-
Beijing, Cina, 100730
- Peking Union Medical College (PUMC) Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age from 18 to 75, male or female
- After abdominal operation of medium scale or above (including but not limited to: gastric cancer eradication, rectal cancer eradication, hepatic lobectomy, corpus and cauda pancreatectomy)
- Hemoglobin (Hb) no less than 70g/L; serum albumin no less than 30 g/L before operation
- Blood loss during operation no more than 2000 ml
Exclusion Criteria:
- Known to be allergic to HES or albumin
- Urine output less than 500 ml/24 hours
- Intra-cranial hemorrhage
- Liver transplantation
- Use colloid other than study drugs
- Lung edema
- Pregnant, lactating female
- Participate in other clinical study within 30 days
- Poor compliance
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
---|
Occurrence of any postoperative complication stipulated in protocol within 28 days after abdominal operation
|
Misure di risultato secondarie
Misura del risultato |
---|
28th day after abdominal operation
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Yupei Zhao, Peking Union Medical College Hospital
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- BFP501
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Hydroxyethyl Starch 130/0.4 (Voluven)
-
The Cleveland ClinicFresenius KabiCompletatoLesione renale postoperatoriaStati Uniti
-
St. Boniface HospitalUniversity of ManitobaSconosciuto
-
Medical University of ViennaCompletatoDisfunsione dell'arteria coronaria | Cardiopatia valvolareAustria
-
Sifa UniversitySconosciutoIpotensione | Anestesia; Effetto avverso, spinale ed epiduraleTacchino
-
Fresenius KabiCompletato
-
SangartCompletatoIschemia | IpotensioneOlanda, Belgio, Svezia, Repubblica Ceca, Polonia
-
SangartCompletatoMalattia vascolare | Ischemia critica degli arti inferioriSvezia
-
Seoul National University HospitalCompletatoDanno renale acutoCorea, Repubblica di
-
SangartCompletatoIschemia | IpotensioneOlanda, Belgio, Repubblica Ceca, Svezia, Polonia, Regno Unito
-
Chung-Ang University Hosptial, Chung-Ang University...SconosciutoTiroidectomia | Reattività fluidaCorea, Repubblica di